Insider trades

Randall Moreadith, Chief Officer of Serina Therapeutics SER, has filed 0 purchases and 41 sales on the open market. Over the past 12 months that comes to a net sale of $501.5K. The latest trade was on 05/21.

Randall Moreadith

Chief Scientific Officer
First filing
25/08/20
Trades
125 trades
Buys / sales
0 / 41
12-month net buying
−$501.5K
Last trade
05/21

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan03/2303/246,500 sh$2.86$18,590−100.0%
Open-market sale10b5-1 plan03/1903/2039,000 sh$2.50$97,500−100.0%
Open-market sale10b5-1 plan02/0202/036,500 sh$3.03$19,695−100.0%
Open-market sale10b5-1 plan01/2801/296,500 sh$3.57$23,205−100.0%
Open-market sale10b5-1 plan01/2201/232,500 sh$2.95$7,375−100.0%
SER
Open-market sale10b5-1 plan01/20–01/2101/214,000 sh2 trades$3.04avg.$12,140−100.0%
SER
Open-market sale10b5-1 plan01/13–01/1401/146,500 sh2 trades$2.50avg.$16,250−100.0%
Open-market sale10b5-1 plan01/0801/0913,000 sh$2.69$34,970−100.0%
Open-market sale10b5-1 plan25/12/2325/12/294,100 sh$2.60$10,660−100.0%
Open-market sale10b5-1 plan25/12/2225/12/235,673 sh$2.67$15,146.91−100.0%
Open-market sale10b5-1 plan25/12/1625/12/173,227 sh$2.96$9,551.92−100.0%
Open-market sale10b5-1 plan25/12/1225/12/161,700 sh$3.26$5,542−100.0%
Open-market sale10b5-1 plan25/12/1125/12/123,555 sh$3.24$11,518.2−100.0%
SER
Open-market sale10b5-1 plan25/12/09–25/12/1025/12/111,245 sh2 trades$3.33avg.$4,146.75−100.0%
SER
Open-market sale10b5-1 plan25/12/02–25/12/0325/12/046,500 sh2 trades$3.61avg.$23,465−100.0%
Open-market sale10b5-1 plan25/11/2525/11/265,965 sh$3.90$23,263.5−50.0%
Open-market sale10b5-1 plan25/11/2425/11/25535 sh$3.94$2,107.9−100.0%
Open-market sale10b5-1 plan25/11/1825/11/196,500 sh$3.75$24,375−100.0%
Open-market sale10b5-1 plan25/11/1025/11/126,500 sh$4.10$26,650−100.0%
Open-market sale10b5-1 plan25/11/0525/11/063,398 sh$4.24$14,407.52−100.0%